# Acute Psychosis Treatment in the Long Term, Unitary Group Study (APLUS)

> **NCT00304655** · PHASE4 · COMPLETED · sponsor: **Korea Otsuka Pharmaceutical Co., Ltd.** · enrollment: 300 (—)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DRUG:** Aripiprazole

## Key facts

- **NCT ID:** NCT00304655
- **Lead sponsor:** Korea Otsuka Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2006-05
- **Final completion:** 2007-10
- **Target enrollment:** 300 (—)
- **Last updated:** 2009-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00304655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00304655, "Acute Psychosis Treatment in the Long Term, Unitary Group Study (APLUS)". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT00304655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*